Market Newsdesk

Allentown, Jan. 15, 2021 (GLOBE NEWSWIRE) — CrossAmerica Partners to Announce

Year-End/Fourth Quarter 2020 Earnings Results on March 1

ALLENTOWN, PA, January 15, 2021 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its year-end/fourth quarter 2020 results after the market closes on Monday, March 1, 2021. In conjunction with the news release, management will host a conference call on Tuesday, March 2, at 9:00 a.m. Eastern Time.

The conference call numbers are 800-774-6070 or 630-691-2753 and the passcode for both is 7265208#. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website (www.crossamericapartners.com).  To listen to the audio webcast, go to https://caplp.gcs-web.com/webcasts-presentations.

After the live conference call, an archive of the webcast will be available on the investor section of the CrossAmerica site at https://caplp.gcs-web.com/webcasts-presentations within 24 hours after the call for a period of sixty days.

About CrossAmerica Partners LP

CrossAmerica Partners is a leading wholesale distributor of motor fuels and owner and lessor of real estate used in the retail distribution of motor fuels. Its general partner, CrossAmerica GP LLC, is indirectly owned and controlled by entities affiliated with Joseph V. Topper, Jr., the founder of CrossAmerica Partners and a member of the board of the general partner since 2012. Formed in 2012, CrossAmerica Partners LP is a distributor of branded and unbranded petroleum for motor vehicles in the United States and distributes fuel to approximately 1,700 locations and owns or leases approximately 1,100 sites. With a geographic footprint covering 34 states, the Partnership has well-established relationships with several major oil brands, including ExxonMobil, BP, Shell, Chevron, Sunoco, Valero, Gulf, Citgo, Marathon and Phillips 66. CrossAmerica Partners ranks as one of ExxonMobil’s largest distributors by fuel volume in the United States and in the top 10 for additional brands. For additional information, please visit www.crossamericapartners.com.

Contacts

Investors:
Randy Palmer, 210-742-8316
[email protected]

DAYTONA BEACH, Fla., Jan. 15, 2021 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) today announced the completion of the previously announced acquisition of O’Leary Insurances by Brown & Brown, Inc.

Brown & Brown, Inc. is a leading insurance brokerage firm, providing risk management solutions to individuals and businesses. With more than 80 years of proven success and thousands of teammates, we offer knowledge you can trust and strive to deliver superior customer service. For more information, please visit bbinsurance.com.

This press release may contain certain statements relating to future results which are forward-looking statements, including those associated with this acquisition. These statements are not historical facts, but instead represent only Brown & Brown’s current belief regarding future events, many of which, by their nature, are inherently uncertain and outside of Brown & Brown’s control. It is possible that Brown & Brown’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further information concerning Brown & Brown and its business, including factors that potentially could materially affect Brown & Brown’s financial results and condition, as well as its other achievements, is contained in Brown & Brown’s filings with the Securities and Exchange Commission. Such factors include those factors relevant to Brown & Brown’s consummation and integration of the announced acquisition, including any matters analyzed in the due diligence process, and material adverse changes in the business and financial condition of the seller, the buyer, or both, and their respective customers. All forward-looking statements made herein are made only as of the date of this release, and Brown & Brown does not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which Brown & Brown hereafter becomes aware.

R. Andrew Watts
Chief Financial Officer
(386) 239-7550

OCALA, Fla., Jan. 15, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has rescheduled its investor conference call for 11:00 a.m. Eastern Time on Thursday, January 21, 2021 to discuss the recently announced commencement of the treatment of subjects with COVID-19-induced chronic fatigue-like symptoms in the amended AMP-511 trial, recent accomplishments and upcoming milestones.

Investors and other interested parties are invited to submit questions to management prior to the call’s start via email to [email protected]. Management respectfully requests that questions be non-compound, direct and addressing single subjects.

The conference call will be available on the Company’s website at https://aimimmuno.com/events-presentations/, or via telephone by dialing toll free 877-407-8031 for U.S. callers, or +1 201-689-8031 for international callers.

For those unable to participate at that time, a replay of the call will be archived on the Company’s website or can be accessed by dialing 877-481-4010 for U.S. callers, or +1 919-882-2331 for international callers and entering the pass code 39447. The replay will be available for 90 days.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Contacts:

Crescendo Communications, LLC
Phone: 212-671-1021
Email: [email protected]

AIM ImmunoTech Inc.
Phone: 800-778-4042
Email: [email protected]

ROAD TOWN, British Virgin Islands, Jan. 15, 2021 (GLOBE NEWSWIRE) — Aura Minerals, Inc. (TSX: ORA) (B3: AURA33) (“Aura Minerals” or the “Company”) is pleased to announce operational and financial guidance for the financial year ending December 31, 2021 in respect of: (i) production of gold equivalent ounces (“GEO”), (ii) cash cost from operations per equivalent ounce of gold produced, and (iii) capital expenditures.

Along with 2021 guidance, the Company is also announcing management’s production targets for 2022-2024.

Rodrigo Barbosa, CEO of Aura, comments: “During the past several years, we focused on (i) developing new strategy and asset portfolio, (ii) strengthening our balance sheet, and (iii) building a culture of responsible and high-performance management. As evidenced by our record preliminary 2020 annual production, this focus is paying off. On January 7, 2021, Aura announced record high production of 204,000 GEO for 2020, and we expect to continue to grow again in 2021 with targeted annual production between 250,000 and 290,000 GEO. Moreover, for the medium term, we set a target to more than double annual production, achieving between 400,000 and 480,000 GEO in 2024, based on the combination of our potential brownfield expansion and existing greenfield projects, not including any potential acquisitions.”

2021 Production Guidance

Aura estimates total production volume for the 2021 to be between 250,000 and 290,000 GEO, as projected in the table below, by business unit:

https://www.globenewswire.com/NewsRoom/AttachmentNg/03bd425c-b4c1-4089-82d9-8fe543c8dd5e

Gold equivalent ounces, or GEO, is calculated by converting the production of silver and copper into gold using a ratio of the prices of these metals to that of gold. The prices used to determine the gold equivalent ounces are based on the weighted average price of silver and copper realized from sales at the Aranzazu Complex during the relevant period, which are assumed to be as follows: Gold = US$ 1,850/oz; Silver = US$ 24.28/oz; Copper = US$ 3.02/lb

Some of the main factors that may impact production results of business units are detailed below:

• San Andres: Esperanza is expected to remain as the main source of ore for 2021. Improvements in the plant are expected to reduce the leaching cycle and reduce DMT in the mine to increase efficiency. The Company also intends to conduct exploration activities to develop new targets surrounding the existing pit.
• EPP: Ernesto pit is expected to be the main source of ore feed for the year, together with the pit development for full production, targeted in 2022. The Company expects the fourth quarter of 2021 to have the most significant production. Japones, Nosde and PPQ are expected to keep producing in 2021, which, together with the development of the extension of Lavrinha pit, is expected to provide more flexibility to EPP with 4 operational pits and one underground mine.
• Aranzazu: Over the first half of the year, the implementation of further improvements in the milling and flotation circuit may increase throughput, reaching 100,000 tons per month during the second half of 2021. More than 48,900m of drilling is planned as part of a strong exploration plan to support the next expansion, in line with management’s goal of doubling production capacity in the future.
• Gold Road: While we move to final phase of the ramp up, exploration efforts are expected to continue in 2021, both at current operational areas as well as targets in the Company’s mineral concession. The Company expects to publish an updated technical report during the first half of 2021.

Please see below under the heading “Technical Disclosure” for reference to the technical reports with respect to the above noted properties and the Company’s most recent Annual Information Form which contain further details and assumptions underlying this guidance.

Management Targets – 2022-2024

In addition to its production guidance for 2021, the Company is pleased to announce management targets for production for 2022-2024 across its business units.

Management has set a production target of 400,000 to 480,000 GEO for the year ending December 31, 2024, as described in the chart below:

https://www.globenewswire.com/NewsRoom/AttachmentNg/9b2302cb-f51e-4f05-8cb6-620c88f5d48f

Notes: 2021 and 2022 figures are based on current technical reports for the Company’s projects, except as otherwise noted. Please refer to the heading “Technical Information”. Figures for 2023-2024 are based on management’s expectations based on preliminary, high level studies for each of the assets. 1) Based on Ausenco’s Desktop Study issued in May 2020, as disclosed in the press release of the Company dated July 21, 2020. These targets are management’s objectives only and are subject to certain risks and assumptions. See “Forward-Looking Information”, below.

2021 Cash Cost per Ounce

Aura estimates that cash cost from operation per equivalent ounce of gold produced (“cash cost per ounce”) for the year ending December 31, 2021 will be within the range of US$728 and US$867.

The table below shows the breakdown of projected cash cost per ounce by business unit:

https://www.globenewswire.com/NewsRoom/AttachmentNg/c753ae3f-20f3-48ef-9dbd-bd1f3c5e6fc1

For cost calculation the Company is considering the following assumptions on exchange rates: for Brazilian Real: BRL 5.20/USD; Honduran Lempira: HNL 24.00/USD; Mexican Peso: MXN 21.00/USD.

2021 Capital Expenditures

In 2021, the Company expects to start the construction of the Almas greenfield project, to develop a pre-feasibility study for the Matupa project and to further expand production capacity at Aranzazu, which, along with sustaining and exploration capital expenditures, will reach a total between US$93 million and US$104 million.

The table below shows the breakdown of capital expenditures by type of investment:

https://www.globenewswire.com/NewsRoom/AttachmentNg/25ea8e4b-c9c4-43d7-b972-0430f3ecd9e2

Aura believes its properties have strong geological potential and management’s objective is to expand life of mine across its business units. Therefore, in 2021, Aura plans to invest a total of US$24 million to US$28 million which includes:

• US$6 million to US$8 million in capital expenditures (included in the table above) in areas where the Company has proven and probable mineral reserves; and,
• US$18 million to US$20 million in exploration expenses, not capitalized, in areas where the Company does not yet have proven and probable mineral reserves (not included in the table above).

Qualified Person

Farshid Ghazanfari, P.Geo., Geology and Mineral Resources Manager for Aura Minerals Inc. has reviewed and confirmed the scientific and technical information contained within this news release and serves as the Qualified Person as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

Technical Disclosure

Reference should be made to the following technical reports for further details and assumptions with respect to certain of the properties described herein:

• the technical report with an effective date of January 31, 2018, and entitled “Feasibility Study of the Re-Opening of the Aranzazú Mine, Zacatecas, Mexico,” prepared for Aura Minerals by F. Ghazanfari, P.Geo. (Farshid Ghazanfari Consulting), A. Wheeler, C.Eng. (Independent Mining Consultant), C. Connors, RM-SME (Aura Minerals Inc.), B. Dowdell, C.Eng. (Dowdell Mining Limited), P. Cicchini P.E. (Call & Nicholas, Inc.), G. Holmes, P.Eng. (Jacobs Engineering), B. Byler, P.E. (Wood Environment and Infrastructure Solutions), C. Scott, P.Eng. (SRK Canada), D. Lister, P.Eng. (Altura Environmental Consulting), F. Cornejo, P.Eng. (Aura Minerals Inc), available under the Company’s SEDAR profile;
• the technical report dated July 2, 2014, with an effective date of December 31, 2013, and entitled “Mineral Resource and Mineral Reserve Estimates on the San Andrés Mine in the Municipality of La Union, in the Department of Copan, Honduras” prepared for Aura Minerals by Bruce Butcher, P.Eng.,former Vice President, Technical Services, Ben Bartlett, FAusiMM, former Manager Mineral Resources and Persio Rosario, P. Eng., former Principal Metallurgist, available under the Company’s SEDAR profile;
• the technical report dated January 13, 2017, with an effective date of July 31, 2016, and entitled “Feasibility Study and Technical Report on the EPP Project, Mato Grosso, Brazil” prepared for Aura Minerals by a group of third-party consultants, including P&E Mining Consultants Inc., MCB Brazil and Knight Piesold Ltd., available under the Company’s SEDAR profile; and,
• the technical report dated May 3, 2018, titled “NI 43-101 Technical Report, Preliminary Economic Assessment of the Gold Road Mine, Arizona, USA” prepared for Soma Gold Corp. (formerly Para Resources Inc., the vendor of the Gold Road Project) by RPM Global, available under Soma’s Gold Corp.’s SEDAR profile.

Non-IFRS Financial Measures

The Company has included certain non-IFRS financial measures in this news release which are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS. Further details on non-IFRS financial measures are provided in the Company’s Management’s Discussion and Analysis accompanying its financial statements filed from time to time on SEDAR at www.sedar.com and at the Company’s website (ir.auraminerals.com).

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements”, as defined in applicable Canadian securities laws (collectively, “forward-looking statements”) which include, but are not limited to, future production across the business units of the Company, the continued development of the Company’s mineral properties, the timing for publishing an updated technical report in respect of the Company’s Gold Road project, future exploration activities, cash cost of operation per ounce of gold equivalent produced and capital expenditures.

Known and unknown risks, uncertainties and other factors, many of which are beyond the Company’s ability to predict or control, could cause actual results to differ materially from those contained in the forward-looking statements. Specific reference is made to the most recent Annual Information Form on file with certain Canadian provincial securities regulatory authorities for a discussion of some of the factors underlying forward-looking statements, which include, without limitation, the development of the Company’s properties and the anticipated timing thereof, expected production from, and the further potential of the Company’s properties, the ability of the Company to achieve its longer-term outlook and the anticipated timing and results thereof, the ability to lower costs and increase production, the ability of the Company to successfully achieve business objectives, copper and gold or certain other commodity price volatility, changes in debt and equity markets, the uncertainties involved in interpreting geological data, increases in costs, environmental compliance and changes in environmental legislation and regulation, interest rate and exchange rate fluctuations, general economic conditions and other risks involved in the mineral exploration and development industry. Readers are cautioned that the foregoing list of factors is not exhaustive of the factors that may affect the forward-looking statements.

All forward-looking statements herein are qualified by this cautionary statement. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements whether as a result of new information or future events or otherwise, except as may be required by law. If the Company does update one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements.

Financial Outlooks and Future-Oriented Financial Information

To the extent any forward looking statements in this press release constitute “financial outlooks” within the meaning of applicable Canadian securities legislation, such information is being provided as certain estimated financial metrics and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Financial outlooks, as with forward-looking statements generally, are, without limitation, based on the assumptions and subject to various risks as set out herein. The Company’s actual financial position and results of operations may differ materially from management’s current expectations and, as a result, may differ materially from values provided in this press release.

About Aura 360° Mining

Aura is focused on mining in complete terms – thinking holistically about how its business impacts and benefits every one of our stakeholders: our company, our shareholders, our employees, and the countries and communities we serve. We call this 360° Mining.

Aura is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The Company’s producing assets include the San Andres gold mine in Honduras, the Ernesto/Pau-a -Pique gold mine in Brazil, the Aranzazu copper-gold-silver mine in Mexico and Gold Road mine in the United States. In addition, the Company has two additional gold projects in Brazil, Almas and Matupá, and one gold project in Colombia, Tolda Fria.

For further information, please visit Aura’s website at www.auraminerals.com or contact:

Rodrigo Barbosa                 
President & CEO                
305-239-9332

Dr. Shujie Cui has developed a (N+S) Antigen test with great sensitivity and is planning to create the first Saliva N+S Antigen Test

San Clemente, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Mr. Strongo, CEO of Global WholeHealth Partners Corp, has encouraged the increase in R&D to make Global the leader in the area of the CoViD 19 SARS 2 testing. Global knows that the market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for Covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.

Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.

With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient’s finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and – to help curb the spread of CoViD19 SARS2.

As a third surge of the coronavirus threatens much of the United States, public health experts across the country say there still aren’t enough tests available to keep the virus under control.

About 30 million Covid-19 tests are given every month, according to estimates from The Atlantic magazine’s Covid Tracking Project. But studies have found that the U.S. would need millions more — 193 million a month, according to one report — to be effective.

The USA has the largest number of Covid-19 cases in the world and there is concern that this next wave of infections will be worse than the previous. Global WholeHealth Partners, Corp. is confident that its Covid-19 Rapid Test can make a difference through assisting companies, staff, and public places where transmission may occur with a reliable, accurate, and fast Rapid Test.

Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, GWHP offers a CE Mark for its high quality, rapid antibody test for COVID-19 and an EUA filing with the FDA is pending approval. In the interim, the US Navy in California has been using the test during 2Q20 and the Company has the capacity to deliver hundreds of thousands of tests, ramping up to almost 1 million per day. Currently, the Company has 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA.

Disclaimer:

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

Media Contact:

Name: Charles Strongo,

CEO, Global WholeHealth Partners Corp.

Email: [email protected]

www.gwhpcorp.com

https://www.globenewswire.com/news-release/2020/12/11/2143930/0/en/The-global-COVID-19-diagnostics-market-by-revenue-is-expected-to-register-a-negative-CAGR-of-9-during-the-period-2021-2026.html

Forward-Looking Statements

This press release contains “forward-looking statements.”  Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

HOUSTON, Jan. 15, 2021 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE:SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore oil and natural gas and wind farm facilities worldwide, today announced that on January 12, 2021, SEACOR Marine completed the previously announced sale of Windcat Workboats Holdings Limited (“Windcat”) and its crew transfer vessel business to Compagnie Maritime Belge (“CMB”), a diversified shipping and logistics group. As consideration for the sale, CMB paid SEACOR Marine £32.8 million in cash, and assumed all of the approximately £20.4 million of debt outstanding under Windcat’s existing revolving credit facility. After deducting transaction costs and expenses and giving effect to foreign exchange rate hedges, the Company received net cash proceeds of approximately US$42.6 million.   Pro forma financial information of the Company giving effect to the closing will be provided in a Current Report on Form 8-K to be filed by the Company today with the Securities and Exchange Commission and available at www.sec.gov.

SEACOR Marine provides global marine and support transportation services to offshore oil and natural gas and windfarm facilities worldwide.  SEACOR Marine and its joint ventures operate a diverse fleet of offshore support and specialty vessels that deliver cargo and personnel to offshore installations; handle anchors and mooring equipment required to tether rigs to the seabed; tow rigs and assist in placing them on location and moving them between regions; provide construction, well workover and decommissioning support; and carry and launch equipment used underwater in drilling and well installation, maintenance and repair.  Additionally, SEACOR Marine’s vessels provide accommodations for technicians and specialists, safety support and emergency response services.

Certain statements discussed in this release as well as in other reports, materials and oral statements that the Company releases from time to time to the public constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Generally, words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “believe,” “plan,” “target,” “forecast” and similar expressions are intended to identify forward-looking statements.  Such forward-looking statements concern management’s expectations, strategic objectives, business prospects, anticipated economic performance and financial condition and other similar matters.  Forward-looking statements are inherently uncertain and subject to a variety of assumptions, risks and uncertainties that could cause actual results to differ materially from those anticipated or expected by the management of the Company.  These statements are not guarantees of future performance and actual events or results may differ significantly from these statements.  Actual events or results are subject to significant known and unknown risks, uncertainties and other important factors, many of which are beyond the Company’s control.  It should be understood that it is not possible to predict or identify all such factors.  Consequently, the preceding should not be considered to be a complete discussion of all potential risks or uncertainties.  Given these risk factors, investors and analysts should not place undue reliance on forward-looking statements.  Forward-looking statements speak only as of the date of the document in which they are made.  The Company disclaims any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in the Company’s expectations or any change in events, conditions or circumstances on which the forward-looking statement is based, except as required by law.  It is advisable, however, to consult any further disclosures the Company makes on related subjects in its filings with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (if any).  These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995.

Please visit SEACOR Marine’s website at www.seacormarine.com for additional information.
For all other requests, contact Connie Morinello at (346) 980-1700 or [email protected]